Medicare Advantage contract
S2874 Humana
Medicare Prescription Drug Plan · Parent: Humana Inc.
⚠ Non-renewal
↓ Churn flag
Latest enrollment
3,962
2024-01
Year-over-year
-9.1%
contract book
National MA share
+0.0%
rank #506 of 984
Overall stars (latest)
—
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | — | — | 3.5 | — |
| 2021 | — | — | 3.0 | — |
| 2022 | — | — | 3.5 | — |
| 2023 | — | — | 2.5 | — |
| 2024 | — | — | 2.5 | — |
Premium
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| S2874-001 | 2024 | $75.90 | $75.90 |
| S2874-004 | 2024 | $44.00 | $44.00 |
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- D01 Call Center Foreign Language Interpreter and TTY Availability 5★ → 3★
- D04 Drug Plan Quality Improvement 2★ → 3★
- D02 Complaints about the Drug Plan 3★ → 4★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →